Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer’s disease in a mouse model
Abstract Blood-brain barrier (BBB) dysfunction is an early pathological hallmark of Alzheimer’s disease (AD), occurring prior to amyloid-β (Aβ) accumulation. A key factor contributing to BBB damage in AD is the loss of endothelial expression of low-density lipoprotein receptor-related protein 1 (LRP...
Saved in:
| Main Authors: | Ting-Ting Pan, Yan-Yun Sun, Yi-Fan Shi, Mei Zhao, Naveed Ullah Khan, Hai-Yan Chen, Wen-Li Ji, Jie Li, Liang Han, Quan-Hong Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Alzheimer’s Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13195-025-01840-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of interval training with curcumin supplementation on LRP1 and beta amyloid levels in rats with Alzheimer\'s disease
by: Mostafa Zarin Afzal, et al.
Published: (2021-12-01) -
The effect of a moderate-intensity interval training on the plasma levels of LDL receptor-related protein-1 (LRP1) and cerebral and plasma levels of amyloid beta in induced Alzheimer\'s rats
by: Mostafa Zarin Afzal, et al.
Published: (2020-12-01) -
Effect of simvastatin on microinflammation in patients with uremia
by: SU Bo, et al.
Published: (2017-01-01) -
Gentisic acid prevents the development of atherosclerotic lesions by inhibiting SNX10-mediated stabilization of LRP6
by: Tongqing Chen, et al.
Published: (2024-12-01) -
Simvastatin-loaded liposomal nanoparticles as treatment for adenomyosis in a patient-derived xenograft mouse model: a pilot study
by: Rachel Michel, et al.
Published: (2025-12-01)